Clinical Trial Update: Study to Investigate the Efficacy and Tolerability of AZD1446 in Adult ADHD Patients. [Phase 2]

View source ↗

Summary

A Phase 2 trial assessing the efficacy and tolerability of AZD1446 for adult attention-deficit/hyperactivity disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• AZD1446

Snippet

Sponsor: AstraZeneca | Conditions: Adult ADHD | Phase 2 | Status: COMPLETED